TW200608992A - Method and formulation for transdermal delivery of immunologically active agents - Google Patents

Method and formulation for transdermal delivery of immunologically active agents

Info

Publication number
TW200608992A
TW200608992A TW094116367A TW94116367A TW200608992A TW 200608992 A TW200608992 A TW 200608992A TW 094116367 A TW094116367 A TW 094116367A TW 94116367 A TW94116367 A TW 94116367A TW 200608992 A TW200608992 A TW 200608992A
Authority
TW
Taiwan
Prior art keywords
immunologically active
active agent
formulation
active agents
transdermal delivery
Prior art date
Application number
TW094116367A
Other languages
English (en)
Inventor
Yuh-Fun Maa
Mahmoud Ameri
Scott Sellers
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of TW200608992A publication Critical patent/TW200608992A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
TW094116367A 2004-05-19 2005-05-19 Method and formulation for transdermal delivery of immunologically active agents TW200608992A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57286104P 2004-05-19 2004-05-19
US11/112,311 US20050266011A1 (en) 2004-05-19 2005-04-21 Method and formulation for transdermal delivery of immunologically active agents

Publications (1)

Publication Number Publication Date
TW200608992A true TW200608992A (en) 2006-03-16

Family

ID=35394844

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094116367A TW200608992A (en) 2004-05-19 2005-05-19 Method and formulation for transdermal delivery of immunologically active agents

Country Status (13)

Country Link
US (1) US20050266011A1 (zh)
EP (1) EP1747672A4 (zh)
JP (1) JP2008507590A (zh)
CN (1) CN101433091A (zh)
AR (1) AR049053A1 (zh)
AU (1) AU2005242409A1 (zh)
CA (1) CA2566759A1 (zh)
IL (1) IL179378A0 (zh)
MX (1) MXPA06013490A (zh)
NO (1) NO20065792L (zh)
TW (1) TW200608992A (zh)
WO (1) WO2005112463A2 (zh)
ZA (1) ZA200610654B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
GB0505518D0 (en) * 2005-03-17 2005-04-27 Chiron Srl Combination vaccines with whole cell pertussis antigen
US8168206B1 (en) * 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
CA2801151A1 (en) * 2010-06-01 2011-12-08 Novartis Ag Concentration of vaccine antigens with lyophilization
KR102471356B1 (ko) * 2010-06-01 2022-11-28 노파르티스 아게 동결건조하지 않는 인플루엔자 백신 항원의 농축
AU2011290471B2 (en) 2010-08-20 2015-08-20 Novartis Ag Soluble needle arrays for delivery of influenza vaccines
US20120219590A1 (en) * 2011-02-24 2012-08-30 Paxvax, Inc. Formulations useful for spray drying vaccines
GB201106802D0 (en) 2011-04-21 2011-06-01 Allergy Therapeutics Ltd Process for preparing vaccine composition
JP2015091791A (ja) * 2013-10-03 2015-05-14 日東電工株式会社 インフルエンザワクチン乾燥製剤、及び、インフルエンザワクチン乾燥製剤の製造方法
US20160310412A1 (en) * 2013-12-16 2016-10-27 Takeda Pharmaceutical Company Limited Microneedle
ES2755815T3 (es) 2016-09-13 2020-04-23 Allergan Inc Composiciones de toxina de Clostridium no proteicas estabilizadas
US11306292B2 (en) * 2017-05-15 2022-04-19 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
MX2021000548A (es) * 2018-07-19 2021-07-02 Glaxosmithkline Biologicals Sa Procesos para preparar polisacáridos en seco.
JP2023522699A (ja) * 2020-04-22 2023-05-31 エマージェクス ユーエスエー コーポレーション コロナウイルスワクチンでコーティングされた微小突起を有する経皮活性剤送達デバイス

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) * 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) * 1972-02-14 1973-08-13 Ici Ltd Pansements
GB1488800A (en) * 1973-11-29 1977-10-12 Wellcome Found Influenza vaccines
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
AU5740496A (en) * 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
AU3399197A (en) * 1996-06-18 1998-01-07 Alza Corporation Device for enhancing transdermal agent delivery or sampling
ATE302041T1 (de) * 1997-12-11 2005-09-15 Alza Corp Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
WO1999029364A1 (en) * 1997-12-11 1999-06-17 Alza Corporation Device for enhancing transdermal agent flux
US6091975A (en) * 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
MXPA03003815A (es) * 2000-10-26 2004-08-12 Johnson & Johnson Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos.
US6855372B2 (en) * 2001-03-16 2005-02-15 Alza Corporation Method and apparatus for coating skin piercing microprojections
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
WO2003049670A2 (en) * 2001-07-27 2003-06-19 Immuno-Rx, Inc. Adjuvant formulations for bacterial and virus vaccines and method of making same
AU2003221888B2 (en) * 2002-04-11 2008-11-06 Medimmune, Llc Preservation of bioactive materials by spray drying
CA2562932A1 (en) * 2004-04-01 2005-10-27 Alza Corporation Apparatus and method for transdermal delivery of influenza vaccine
MXPA06011971A (es) * 2004-04-13 2007-04-16 Johnson & Johnson Aparato y metodo para suministro transdermico de multiples vacunas.

Also Published As

Publication number Publication date
WO2005112463A2 (en) 2005-11-24
US20050266011A1 (en) 2005-12-01
ZA200610654B (en) 2008-06-25
CA2566759A1 (en) 2005-11-24
JP2008507590A (ja) 2008-03-13
CN101433091A (zh) 2009-05-13
AR049053A1 (es) 2006-06-21
WO2005112463A3 (en) 2009-05-14
NO20065792L (no) 2007-02-14
IL179378A0 (en) 2007-03-08
EP1747672A2 (en) 2007-01-31
AU2005242409A1 (en) 2005-11-24
MXPA06013490A (es) 2007-06-12
EP1747672A4 (en) 2010-02-17

Similar Documents

Publication Publication Date Title
TW200608992A (en) Method and formulation for transdermal delivery of immunologically active agents
WO2005041871A3 (en) Apparatus and method for enhancing transdermal drug delivery
GB0109297D0 (en) Vaccine
TW200640486A (en) Composition
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
AR032597A1 (es) Uso de antigenos del virus de la gripe inactivado, en la preparacion de vacunas de una sola dosis intranasal; metodo para la profilaxis de enfermedades o de infecciones gripales en pacientes; equipos que comprenden dichas vacunas en dosis unicas y metodo para fabricar vacunas para la gripe para apli
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
TW200600107A (en) Apparatus and method for transdermal delivery of multiple vaccines
MXPA05010196A (es) Nuevas formulaciones y su uso.
WO2002028422A3 (en) Split enveloped virus preparation for intranasal delivery
WO2014096985A3 (en) A stable aqueous composition comprising human insulin or an analogue or derivative thereof
NO20082988L (no) Vedvarende frigivningsformulering innbefattende oktreotid og to eller flere polylaktid-ko-glykolidpolymerer
PL1643833T3 (pl) Formulacje agrochemiczne
EP1426066A4 (en) FRUIT PRODUCT FOR THE CONSTRUCTION OF HUMAN BONE FABRIC, METHOD FOR ITS MANUFACTURE AND APPLICATION AREAS
MX349090B (es) Dispositivo separador modular para el tratamiento de infecciones de la prótesis de las extremidades humanas.
MX2013012206A (es) Metodo para producir substancias con gas sobresaturado,dispositivo de suministro transdermico de las mismas, y usos de las mismas.
HK1106447A1 (en) Liquid allergy vaccine formulation for oromucosal administration
GB2446341A (en) Method and system for transdermal drug delivery
WO2012145555A3 (en) Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
EP1667634A4 (en) ANTHRAX VACCINE
WO2004043486A8 (en) An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism
PL371518A1 (en) Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations
WO2002036160A3 (es) Método de obtención de estructuras antigénicas que potencian la reactividad cruzada específica
AR046221A1 (es) Formulaciones farmaceuticas
UA97044C2 (ru) Средство противовирусной и иммуностимулирующей активности, способ получения средства противовирусной и иммуностимулирующей активности, способ профилактики и лечения инфекционных болезней